Paragon Bioservices will be attending and or exhibiting at the following events.
for Outsourcing Drug Development and Manufacturing
July 17 – 18, 2018
JOIN THE CONVERSATION
Follow us on social media!
Check out our latest official news!
Baltimore, MD, May 18, 2018 - Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, was named the...
Company will open new manufacturing facility; plans to create 200 new jobs BALTIMORE, MD (March 19, 2018) – The state of Maryland and the Anne Arundel County Economic Development Corp. (AAEDC) announced today their support of Paragon...
Company Appoints Philip Wills as Chief Commercial Officer, John Conner as Chief Manufacturing Officer and William Thomas, Jr., as Chief Scientific Officer New Hires Include Randy Henrickson, VP of Manufacturing, and Dermot McCaul, VP of Information...
Growing client need for broad gene therapy manufacturing capacity drives investment in new facilities Baltimore, MD, January 23, 2018 - Paragon Bioservices (Paragon), the leading private equity-backed biologics contract development and...